Mural honoring scientists in NYC seeks new patron after 60 years

A mural that has been a prominent feature in Pfizer's New York City headquarters for over six decades is in jeopardy of being dismantled if a new patron is not found soon. The mural, created by Greek American artist Nikos Bel-Jon, measures 40 feet wide and 18 feet high, depicting various figures in medicine through dynamic metal panels. Pfizer, having moved its headquarters to a new location, has decided that the funds required for the mural's relocation would be better allocated to patient-related initiatives. The building is now being converted into apartments by Metro Loft, which also does not wish to retain the artwork. Art conservationists, along with Bel-Jon's daughters, are actively seeking a new home for the mural, ideally in an educational setting such as a hospital or university. They have received interest from some universities and a Greek cultural organization that may assist with fundraising efforts. The estimated cost for the removal and reinstallation of the mural ranges from $20,000 to $50,000, which poses a significant challenge in securing the necessary funds. Despite the mural's current dull appearance, Bel-Jon Calkins recalls its original vibrant colors that changed with movement, highlighting its unique artistic quality. Experts have noted that while the mural may not have substantial commercial value, its historical significance warrants preservation. The urgency to find a suitable location for the mural is critical, as time is running out to prevent it from being lost or destroyed, following a trend where corporate art has been neglected or discarded in the past.